Twelve-year-old Lucas Polsinelli is in 7th grade and has been receiving treatment for B-cell Acute Lymphoblastic Leukemia at ...

The first patients have been dosed in a trial of CAR T therapy in relapsed/refractory T cell acute lymphoblastic leukemia or ...

Previously reported Phase 1/2 data on WU-CART-007 demonstrated clinically manageable safety and evidence of anti-leukemic activity with an ...

El Paso Franklin High School girls soccer player Scarlett Orwig overcomes Leukemia to find success and is the leading goal ...

The combination therapy is now an option for patients with Philadelphia chromosome-negative, CD19-positive B-cell precursor acute lymphoblastic leukaemia (ALL), even if they have no detectable ...

Therapy-related B-cell acute lymphoblastic leukemia (B-ALL), a rare form of acute lymphoblastic leukemia (ALL), may develop in patients receiving cytotoxic treatments for a prior malignancy, according ...

Treatment with the T-cell immunotherapy Orca-T improved survival free of moderate-to-severe chronic graft-versus-host disease ...

The firm also said its partner BioNTech won't exercise its option rights for the CD19- and CD22-directed CAR T-cell therapy candidate AUTO1/22.

Shares of AIkido Pharma Inc. (NASDAQ:AIKI – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.79 and traded as high as ...